E1 initial reporter facility: (b)(6) hospital.The product investigation was completed.Device evaluation details: the device was returned to biosense webster (bwi) for evaluation.A visual inspection of the returned device was performed in accordance with bwi procedures.Visual analysis was performed and the pebax component was torn from its place and not returned for investigation.For this condition, the electrical printed circuit board (pcb) was reviewed, and the values were found within specification.A manufacturing record evaluation was performed for the finished device 31199660m, and no internal action was found during the review.The force issue reported by the customer was not confirmed since the electrical pcb was found within specification.The potential cause of the pebax condition could be related to the manipulation of the device after procedure however, this cannot be conclusively determined.The instructions for use (ifu) contain the following information that should be considered: if force readings might be inaccurate or another catheter is in proximity: an alert message appears, force readings on the dashboard are displayed in gray, and the force graph is colored white.Resolve the issue according to the directions in the alert message to enable force measurement.You can also continue the study without force data.As part of biosense webster's quality process, all devices are manufactured, inspected, and released to approved specifications.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|